Lifesciences investment firm Iguana Healthcare Partners raises $53.5 million in pooled interests.
New York-based lifesciences investment group Iguana Healthcare Partners filed an amended notice, reporting that the company has raised more than $53.5 million in pooled investment fund interests.
The funding, raised among 20 unnamed investors, will support Iguana's interests in pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services and healthcare information technology.
"Our research strategy is bottom-up and stock-by-stock and will focus on innovation and pharmaco-economics as a driver of sales and earnings growth," according to the company's website. "Global and sector-specific risk will be actively managed with an eye on capital preservation."
The fundraising efforts began Jan. 4, 2010, and is set to expire Aug. 31, 2015, according to an SEC filing.
CorMatrix secure FDA clearance for its CanGaroo ECM envelope for use with implantable cardiac devices...
First noninvasive total haemoglobin (SpHb) spot-check sensor for infants and small children.
Masimo wins clearance in Japan and approval in Europe for its rainbow DCI-mini non-invasive...
Here's a look at some of the top Wall Street stories for medical device companies this week: Covidien...
GI Dynamics names ex-ATS Medical chief Michael Dale to replace Stuart Randle as CEO.